Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
To minimise hypoglycaemia risk, patients should: Reduce mealtime insulin by 50% at the start of treatment , then adjust based on blood glucose monitoring Not inject pramlintide if a meal is to be skipped or if a very low-carbohydrate meal is planned Increase the frequency of self-monitoring of blood glucose (SMBG) during initiation and dose adjustment Always carry fast-acting glucose (e.g., glucose tablets or a sugary drink) in case of hypoglycaemia The most commonly reported side effects include: Nausea the most frequent adverse effect, occurring in up to 3040% of patients (per FDA Prescribing Information), particularly during the titration phase Vomiting Anorexia and reduced appetite which, while contributing to weight loss, can be problematic in some patients Injection site reactions including redness, bruising, or discomfort Headache and fatigue Nausea typically diminishes over time with gradual dose titration, and patients should be counselled to expect this during the initial weeks of treatment
In one study, researchers found that subjects experienced mild flushing in the face after growth hormone releasing peptide administration [11]
Epitalon is studied in laboratory environments for its association with telomere biology, gene expression signaling, and neuroendocrine regulatory pathways
Cell Mol Life Sci 65:982990 White HL, Scates PW (1990) Acetyl-l-carnitine as a precursor of acetylcholine
Genetic experiments showed that IGF-1R inactivation in skin results in a disrupted epidermis
US$ 21.52
US$ 29.52
US$ 21.97
US$ 23.02
